These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31039745)

  • 21. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine.
    Zyoud SH; Daraghmeh DN; Mezyed DO; Khdeir RL; Sawafta MN; Ayaseh NA; Tabeeb GH; Sweileh WM; Awang R; Al-Jabi SW
    BMC Nephrol; 2016 Apr; 17(1):44. PubMed ID: 27117687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
    Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; Macleod A
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003963. PubMed ID: 15495072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis.
    Wong CKH; Chen JY; Fung SKS; Lo WK; Lui SL; Chan TM; Cheng YL; Kong I; Wan EYF; Lam CLK
    Nephrology (Carlton); 2019 Jun; 24(6):630-637. PubMed ID: 29926521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine.
    Samoudi AF; Marzouq MK; Samara AM; Zyoud SH; Al-Jabi SW
    Health Qual Life Outcomes; 2021 Feb; 19(1):39. PubMed ID: 33531025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in patients on hemodialysis and peritoneal dialysis.
    Okpechi IG; Nthite T; Swanepoel CR
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):519-26. PubMed ID: 23640624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current state of continuous ambulatory peritoneal dialysis in Egypt.
    Elzorkany KMA
    Saudi J Kidney Dis Transpl; 2017; 28(6):1369-1374. PubMed ID: 29265049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Cardiac Outcome of Continuous Ambulatory Peritoneal Dialysis & Hemodialysis in CKD5 Patients with Heart Failure.
    Barman TK; Roy S; Hossain SM; Salahuddin AZ; Huq MO
    Mymensingh Med J; 2020 Oct; 29(4):793-799. PubMed ID: 33116079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis.
    Kobayashi S; Maejima S; Ikeda T; Nagase M
    Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.
    Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F
    Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome assessment of the Ministry of Health Malaysia dialysis programme.
    Lim TO; Lim YN; Wong HS; Ahmad G; Singam TS; Morad Z; Suleiman AB; Rozina G; Ong LM; Hooi LS; Shaariah W; Tan CC; Loo CS
    Med J Malaysia; 1999 Dec; 54(4):459-70. PubMed ID: 11072463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional status of CAPD patients and their mood state, dialysis dose, comorbidity and quality of life.
    Phillips L; Davies SJ; Russell GI
    EDTNA ERCA J; 1996; 22(3):11-4. PubMed ID: 10723325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive Symptoms, Patient Satisfaction, and Quality of Life Over Time in Automated and Continuous Ambulatory Peritoneal Dialysis Patients: A Prospective Multicenter Propensity-Matched Study.
    Jung HY; Jang HM; Kim YW; Cho S; Kim HY; Kim SH; Bang K; Kim HW; Lee SY; Jo SK; Lee J; Choi JY; Cho JH; Park SH; Kim CD; Kim YL;
    Medicine (Baltimore); 2016 May; 95(21):e3795. PubMed ID: 27227956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.
    Tonbul HZ; Demir M; Altintepe L; Güney I; Yeter E; Türk S; Yeksan M; Yildiz A
    Ren Fail; 2006; 28(4):287-94. PubMed ID: 16771243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.